Publicaciones (22) Publicaciones de LUIS FIGUERO PÉREZ

2024

  1. Acute pulmonary embolism masking a pulmonary artery sarcoma

    Medicina Clinica

  2. COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES

    European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1

  3. Cáncer de mama

    Oncología clínica (Arán Ediciones), pp. 203-226

  4. No one writes to the colonel: (Pag.-e 102173)

    Semergen: revista española de medicina de familia, Núm. 4, pp. 10-10

  5. Tratamiento Sistémico del Cáncer (II): hormonoterapia

    Oncología clínica (Arán Ediciones), pp. 89-99

2023

  1. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  2. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

  3. Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2

    Reumatologia clinica, Vol. 19, Núm. 2, pp. 121

2022

  1. Acquired haemophilia A secondary to metastatic prostate cancer

    Medicina Clinica

  2. Acute esophageal necrosis induced by immune checkpoint inhibitors

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183

  3. Cancer and elderly: Two incompatible concepts for intensive care?

    Revista Espanola de Geriatria y Gerontologia

  4. Ileal plasmablastic lymphoma presenting as intestinal occlusion in an HIV-negative patient with chronic lymphocytic leukemia

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 4, pp. 242-243

  5. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  6. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

    Reumatologia Clinica, Vol. 17, Núm. 10, pp. 559-561

  2. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  3. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  4. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  5. Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

    CASE REPORTS IN ONCOLOGICAL MEDICINE, Vol. 2021

  6. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18